Angiotech to webcast conference call discussing third quarter 2005 financial results
24 Oktober 2005 - 11:05PM
PR Newswire (US)
VANCOUVER, Oct. 24 /PRNewswire-FirstCall/ -- Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), will
webcast its conference call discussing financial results for the
third quarter ended September 30, 2005 on Thursday, November 3rd,
2005 at 2:00 PM PST (5:00 PM EST). The webcast will be available to
all interested parties through Angiotech's website at
http://www.angiotech.com/ under Investor Relations or by dialing
toll-free in North America to 866-383-8108 (International callers
please dial 617-597-5343) and entering Passcode 27335122. To ensure
a timely connection to the webcast it is recommended that users
register approximately 15 minutes before the conference call. A
recording of the call will be available until Thursday, November
10, 2005 by dialing toll-free in North America 888-286-8010
(International at 617-801-6888) and entering Passcode 50587442. A
press release will be issued prior to the conference call. The
conference call will be hosted by William Hunter, President and
Chief Executive Officer, and David Hall, Chief Financial Officer.
The webcast will be available for seven days on the Angiotech
website. Vancouver-based Angiotech Pharmaceuticals, Inc. is a
specialty pharmaceutical company pioneering the combination of
pharmaceutical compounds with medical devices and biomaterials to
both create novel solutions for poorly addressed disease states and
dramatically improve surgical outcomes. To find out more about
Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP),
please visit our website at http://www.angiotech.com/ FOR
ADDITIONAL INFORMATION: --------------------------- Analysts and
Investors: Todd Young, Vice President Investor Relations and
Communications, Angiotech Pharmaceuticals, Inc. (604) 221-7676 ext
6933 Analysts: Rui Avelar, Senior Vice President Medical Affairs
and Communications, Angiotech Pharmaceuticals, Inc. (604) 221-7676
ext 6996 Media: Wendy Carhart, Waggener Edstrom Bioscience, (503)
443-7354, Email: DATASOURCE: Angiotech Pharmaceuticals, Inc.
CONTACT: Analysts and Investors: Todd Young, Vice President
Investor Relations and Communications, Angiotech Pharmaceuticals,
Inc., (604) 221-7676 ext 6933; Analysts: Rui Avelar, Senior Vice
President Medical Affairs and Communications, Angiotech
Pharmaceuticals, Inc., (604) 221-7676 ext 6996; Media: Wendy
Carhart, Waggener Edstrom Bioscience, (503) 443-7354, Email:
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals - Common Shares (MM) News-Artikel